Gregory A. Grabowski

17.8k total citations · 2 hit papers
261 papers, 13.6k citations indexed

About

Gregory A. Grabowski is a scholar working on Physiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Gregory A. Grabowski has authored 261 papers receiving a total of 13.6k indexed citations (citations by other indexed papers that have themselves been cited), including 212 papers in Physiology, 139 papers in Molecular Biology and 103 papers in Cell Biology. Recurrent topics in Gregory A. Grabowski's work include Lysosomal Storage Disorders Research (211 papers), Cellular transport and secretion (96 papers) and Carbohydrate Chemistry and Synthesis (80 papers). Gregory A. Grabowski is often cited by papers focused on Lysosomal Storage Disorders Research (211 papers), Cellular transport and secretion (96 papers) and Carbohydrate Chemistry and Synthesis (80 papers). Gregory A. Grabowski collaborates with scholars based in United States, Australia and Germany. Gregory A. Grabowski's co-authors include David P. Witte, Ying Sun, Ying Sun, Xiaoyang Qi, Yongping Xu, Hong Du, Robert J. Desnick, Brian Quinn, Marie Grace and Ellen Sidransky and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Gregory A. Grabowski

260 papers receiving 13.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies

2011 1.0k citations Ying Sun, Gregory A. Grabowski et al. profile →
An in vivo model of human small intestine using pluripotent stem cells

2014 422 citations Ying Sun, Gregory A. Grabowski et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory A. Grabowski United States	63	9.2k	5.7k	5.1k	2.9k	2.6k	261	13.6k
Elizabeth F. Neufeld United States	62	6.9k 0.7×	5.8k 1.0×	3.2k 0.6×	2.5k 0.8×	2.1k 0.8×	162	12.6k
Hitoshi Sakuraba Japan	42	5.3k 0.6×	2.9k 0.5×	2.1k 0.4×	1.6k 0.5×	2.3k 0.9×	238	7.6k
Nina Raben United States	52	4.1k 0.4×	3.1k 0.5×	1000 0.2×	729 0.2×	2.7k 1.0×	115	8.1k
Volkmar Gieselmann Germany	48	3.7k 0.4×	3.9k 0.7×	1.8k 0.4×	697 0.2×	1.5k 0.6×	187	7.4k
James A. Shayman United States	49	2.7k 0.3×	4.7k 0.8×	1.6k 0.3×	850 0.3×	806 0.3×	160	7.4k
Dieter Hartmann Germany	53	2.9k 0.3×	6.1k 1.1×	1.7k 0.3×	181 0.1×	1.3k 0.5×	99	11.9k
Peter G. Pentchev United States	43	4.6k 0.5×	2.6k 0.5×	1.4k 0.3×	1.6k 0.5×	713 0.3×	111	6.7k
Rosa Puertollano United States	51	2.2k 0.2×	4.8k 0.8×	3.7k 0.7×	148 0.1×	3.4k 1.3×	106	9.6k
Alex Toker United States	73	1.4k 0.1×	15.1k 2.6×	3.7k 0.7×	429 0.1×	943 0.4×	136	20.5k
Yo Sasaki Japan	63	2.0k 0.2×	5.3k 0.9×	1.2k 0.2×	166 0.1×	2.8k 1.1×	289	15.9k

Countries citing papers authored by Gregory A. Grabowski

Since Specialization

Citations

This map shows the geographic impact of Gregory A. Grabowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory A. Grabowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory A. Grabowski more than expected).

Fields of papers citing papers by Gregory A. Grabowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory A. Grabowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory A. Grabowski. The network helps show where Gregory A. Grabowski may publish in the future.

Co-authorship network of co-authors of Gregory A. Grabowski

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory A. Grabowski. A scholar is included among the top collaborators of Gregory A. Grabowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory A. Grabowski. Gregory A. Grabowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grabowski, Gregory A., Priya S. Kishnani, Roy N. Alcalay, et al.. (2025). Challenges in Gaucher disease: Perspectives from an expert panel. Molecular Genetics and Metabolism. 145(1). 109074–109074. 3 indexed citations

Magnusen, Albert Frank, et al.. (2021). C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease. International Journal of Molecular Sciences. 22(23). 12712–12712. 10 indexed citations

Sun, Ying, Benjamin Liou, Zhengtao Chu, et al.. (2020). Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease. EBioMedicine. 55. 102735–102735. 26 indexed citations

El‐Beshlawy, Amal, Anna Tylki‐Szymańska, Ashok Vellodi, et al.. (2016). Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. Molecular Genetics and Metabolism. 120(1-2). 47–56. 41 indexed citations

Dasgupta, Nupur, Yongping Xu, Ronghua Li, et al.. (2015). Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model. Human Molecular Genetics. 24(24). ddv404–ddv404. 42 indexed citations

Akil, Omar, Ying Sun, Sarath Vijayakumar, et al.. (2015). Spiral Ganglion Degeneration and Hearing Loss as a Consequence of Satellite Cell Death in Saposin B-Deficient Mice. Journal of Neuroscience. 35(7). 3263–3275. 22 indexed citations

He, Xu, Jason D. Galpin, Yansong Miao, et al.. (2014). Membrane anchors effectively traffic recombinant human glucocerebrosidase to the protein storage vacuole of Arabidopsis seeds but do not adequately control N-glycan maturation. Plant Cell Reports. 33(12). 2023–2032. 1 indexed citations

Cullen, Valerie, S. Pablo Sardi, Juliana Ng, et al.. (2011). Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing. Annals of Neurology. 69(6). 940–953. 253 indexed citations

Burrow, Thomas Andrew & Gregory A. Grabowski. (2011). Velaglucerase alfa in the treatment of Gaucher disease type 1. Clinical Investigation. 1(2). 285–293. 21 indexed citations

10.

Sun, Ying & Gregory A. Grabowski. (2010). Impaired autophagosomes and lysosomes in neuronopathic Gaucher disease. Autophagy. 6(5). 648–649. 42 indexed citations

11.

Sun, Yunpeng, Huimin Ran, Kazuyuki Kitatani, et al.. (2009). Specific saposin C deficiency: CNS impairment and acid -glucosidase effects in the mouse. Human Molecular Genetics. 19(4). 634–647. 31 indexed citations

12.

Rosenbaum, Anton I., Madalina Rujoi, Amy Y. Huang, et al.. (2009). Chemical screen to reduce sterol accumulation in Niemann–Pick C disease cells identifies novel lysosomal acid lipase inhibitors. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1791(12). 1155–1165. 46 indexed citations

13.

Du, Hong, Stephen J. Garger, Gregory P. Pogue, et al.. (2008). Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice. Journal of Lipid Research. 49(8). 1646–1657. 54 indexed citations

14.

Nietupski, Jennifer B., Wei‐Lien Chuang, Donna Armentano, et al.. (2006). AAV8‐mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease. The Journal of Gene Medicine. 8(6). 719–729. 49 indexed citations

15.

Zhou, Dapeng, Carlos Cantu, Yuval Sagiv, et al.. (2003). Editing of CD1d-Bound Lipid Antigens by Endosomal Lipid Transfer Proteins. Science. 303(5657). 523–527. 263 indexed citations

16.

Du, Hong, Sulaiman Sheriff, Jorge A. Bezerra, Tatyana Leonova, & Gregory A. Grabowski. (1998). Molecular and Enzymatic Analyses of Lysosomal Acid Lipase in Cholesteryl Ester Storage Disease. Molecular Genetics and Metabolism. 64(2). 126–134. 44 indexed citations

17.

Grabowski, Gregory A.. (1997). Gaucher Disease: Gene Frequencies and Genotype/Phenotype Correlations. Genetic Testing. 1(1). 5–12. 124 indexed citations

18.

Grace, Marie, et al.. (1992). Gaucher disease: Four rare alleles encoding F213I, P289L, T323I, and R463C in type 1 variants. Human Mutation. 1(5). 423–427. 32 indexed citations

19.

Grabowski, Gregory A., et al.. (1990). Acid β-Glucosidase: Enzymology and Molecular Biology of Gaucher Diseas. Critical Reviews in Biochemistry and Molecular Biology. 25(6). 385–414. 125 indexed citations

20.

Graves, Peter N., et al.. (1988). Gaucher Disease Type 1: Cloning and Characterization of a cDNA Encoding Acid β-Glucosidase from an Ashkenazi Jewish Patient. DNA. 7(8). 521–528. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact